307002-71-7
|
|
|
- CAS号:
- 307002-71-7
- 英文名:
- CL 82198 HYDROCHLORIDE
- 英文别名:
- CL-82198
(CL82198;CL 82198 hydrochlori;CL 82198 HYDROCHLORIDE;CL-82198, 10 mM in DMSO;N-(4-Morpholinobutyl)benzofuran-2-carboxamide;N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide;2-Benzofurancarboxamide, N-[4-(4-morpholinyl)butyl]-;CL-82198, Matrix metalloprotinase -13 (MMP-13) inhibitor;Benzofuran-2-carboxylic acid (4-morpholin-4-yl-butyl)-amide;N-(4-Morpholinobutyl)benzofuran-2-carboxamide hydrochloride
- 中文名:
- 307002-71-7
- 中文别名:
- 化合物CL-82198;CL-82198,MMP-13抑制剂;N-(4-吗啉丁基)苯并呋喃-2-甲酰胺;化合物CL-82198,10 MM DMSO 溶液;CL-82198,MATRIX METALLOPROTINASE -13 (MMP-13)抑制剂
- CBNumber:
- CB42450342
- 分子式:
- C17H22N2O3
- 分子量:
- 302.37
- MOL File:
- 307002-71-7.mol
|
|
|
307002-71-7化学性质
-
沸点:
-
515.6±40.0 °C(Predicted)
-
|
-
密度:
-
1.159±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: >10mg/mL
-
|
-
酸度系数(pKa):
-
14.19±0.46(Predicted)
-
|
-
形态:
-
powder
-
|
-
颜色:
-
white to off-white
-
|
-
稳定性:
-
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 6 months.
-
|
307002-71-7性质、用途与生产工艺
CL-82198 是一个选择性的 MMP-13 抑制剂。CL-82198 与 MMP-13 的整个 S1' 口袋结合，这是其对 MMP-13 选择性和对其他 MMP 缺乏抑制活性的基础。CL-82198 可用于骨关节炎 (OA) 的研究。
CL-82198 (10 μM; 24 hours) significantly reduces LS174 cell migration.
CL-82198 decreases CTGF and TGF-β1 protein levels in hepatic stellate cells.
CL82198 (1-10 mg/kg; i.p.; every other day for 12 weeks) prevents and decelerates MLI-induced osteoarthritis progression.
|
Animal Model:
|
10-week-old C57BL/6J mice (performed MLI surgery)
|
|
Dosage:
|
1, 5, 10 mg/kg body weight
|
|
Administration:
|
Intraperitoneal injection; every other day for 12 weeks
|
|
Result:
|
Prevented and decelerated MLI-induced osteoarthritis progression.
|
307002-71-7
上下游产品信息
上游原料
下游产品
307002-71-7, 307002-71-7 相关搜索:
- Angiogenesis and Metastasis
- Protease inhibitor
- 抑制剂
- 合成有机化合物配体
- C17H33N2O3HCl
- 化合物CL-82198,10 MM DMSO 溶液
- CL-82198,MATRIX METALLOPROTINASE -13 (MMP-13)抑制剂
- CL-82198,MMP-13抑制剂
- 化合物CL-82198
- N-(4-吗啉丁基)苯并呋喃-2-甲酰胺
- 307002-71-7
- CL-82198, 10 mM in DMSO
- CL-82198, Matrix metalloprotinase -13 (MMP-13) inhibitor
- Inhibitor,CL-82198,CL82198,MMP,inhibit,Matrix metalloproteinases,CL 82198
- N-(4-Morpholinobutyl)benzofuran-2-carboxamide
- CL 82198 hydrochlori
- 2-Benzofurancarboxamide, N-[4-(4-morpholinyl)butyl]-
- CL-82198
(CL82198
- Benzofuran-2-carboxylic acid (4-morpholin-4-yl-butyl)-amide
- N-(4-Morpholinobutyl)benzofuran-2-carboxamide hydrochloride
- N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide,hydrochloride
- N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide
- N-[4-(4-MORPHOLINYL)BUTYL]-2-BENZOFURANCARBOXAMIDE HYDROCHLORIDE
- CL 82198 HYDROCHLORIDE